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contrast and diffusion MRI parameters
in histogram analysis of gliomas
Hildebrand Dijkstra1 , Paul E Sijens1 , Anouk van der Hoorn1
and Peter Jan van Laar1,2
Abstract
Background: Dynamic-susceptibility contrast and diffusion-weighted imaging are promising techniques in diagnosing
glioma grade.
Purpose: To compare the inter-observer reproducibility of multiple dynamic-susceptibility contrast and diffusion-
weighted imaging parameters and to assess their potential in differentiating low- and high-grade gliomas.
Material and Methods: Thirty patients (16 men; mean age¼ 40.6 years) with low-grade (n¼ 13) and high-grade
(n¼ 17) gliomas and known pathology, scanned with dynamic-susceptibility contrast and diffusion-weighted imaging
were included retrospectively between March 2006 and March 2014. Three observers used three different methods
to define the regions of interest: (i) circles at maximum perfusion and minimum apparent diffusion coefficient;
(ii) freeform 2D encompassing the tumor at largest cross-section only; (iii) freeform 3D on all cross-sections. The
dynamic-susceptibility contrast curve was analyzed voxelwise: maximum contrast enhancement; time-to-peak; wash-in
rate; wash-out rate; and relative cerebral blood volume. The mean was calculated for all regions of interest. For 2D and
3D methods, histogram analysis yielded additional statistics: the minimum and maximum 5% and 10% pixel values of the
tumor (min5%, min10%, max5%, max10%). Intraclass correlations coefficients (ICC) were calculated between observers.
Low- and high-grade tumors were compared with independent t-tests or Mann–Whitney tests.
Results: ICCs were highest for 3D freeform (ICC¼ 0.836–0.986) followed by 2D freeform (ICC¼ 0.854–0.974) and
circular regions of interest (0.141–0.641). High ICC and significant discrimination between low- and high-grade gliomas
was found for the following optimized parameters: apparent diffusion coefficient (P< 0.001; ICC¼ 0.641; mean; circle);
time-to-peak (P¼ 0.015; ICC¼ 0.986; mean; 3D); wash-in rate (P¼ 0.004; ICC¼ 0.826; min10%; 3D); wash-out rate
(P< 0.001; ICC¼ 0.860; min10%; 2D); and relative cerebral blood volume (P 0.001; ICC¼ 0.961; mean; 3D).
Conclusion: Dynamic-susceptibility contrast perfusion parameters relative cerebral blood volume and time-to-peak
yielded high inter-observer reproducibility and significant glioma grade differentiation for the means of 2D and 3D
freeform regions of interest. Choosing a freeform 2D method optimizes observer agreement and differentiation in
clinical practice, while a freeform 3D method provides no additional benefit.
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Introduction
Grading of gliomas, the most common primary brain
tumor (1,2), is important since the prognosis and adju-
vant therapy after surgery differ according to tumor
grade (3,4). Conventional imaging parameters, such as
contrast enhancement on T1-weighted magnetic reso-
nance imaging (MRI), donot provide a reliable indicator
of tumor grade (5,6).Diffusion-weighted imaging (DWI)
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and perfusion-weighted imaging (PWI) provide a pleth-
ora of additional parameters to overcome the shortcom-
ings of conventional MRI. Differentiation between low
and high glioma tumor grades has been demonstrated
with dynamic susceptibility-weighed (DSC)-MRI, yield-
ing the relative cerebral blood volume (rCBV) (7–11).
Additionally, the additional value has been documented
of dynamic contrast-enhanced (DCE)-MRI derived
parameters such as blood plasma volume (Vp) (7,8),
volume transfer constant (Ktrans) (7,8,10,12), rate con-
stant (kep) (9,10), and normalized tumor cerebral blood
flow (nCBF) (10,12,13). In addition, quantitative DWI
expressed in the apparent diffusion coefficient (ADC)
shows significant differences between low- and high-
grade gliomas (8,13,14).
In our opinion, a systematic review of the robustness
of the various quantitative measures of perfusion and
diffusion in brain tumors, and of the impact of the
methodology of region of interest (ROI) selection, is
lacking. The purpose of this study was therefore to
compare inter-observer reproducibility of DSC-MRI
and DWI-derived tumor characteristics in 30 gliomas.
Three observers analyzed the MRIs according to the
common practice of manual delineation of the tumor
as visualized on the respective PWI and DWI series,
and of the equally widespread use of small circular
ROIs to simulate fast evaluation in clinical practice.
Interclass correlation coefficients (ICC) were deter-
mined and differentiation between low- and high-
grade glioma was assessed for each parameter.
Material and Methods
Study population
The protocol of this retrospective study was approved
by the hospital’s institutional review board and
patients’ written informed consent was waived.
Between March 2006 and March 2014, patients with
suspected brain lesions and scheduled for MRI were
recruited. Inclusion criteria were: MRI scan protocol
including both DSC and DWI series; and lesion diame-
ter 2 cm on MRI. This resulted in the inclusion of
30 consecutive patients (16 boys/men; mean age¼ 40.6
years; age range¼ 5–78 years) with 30 lesions: 13 were
low-grade and 17 were high-grade. Tissue samples were
obtained in all patients using neuro-navigational guided
core biopsy (n¼ 13) or surgical resection (n¼ 17).
MR protocols
All participants were examined on a 1.5-T MRI system
(Magnetom Sonata, Siemens Medical Solutions,
Erlangen, Germany) using the eight-channel head coil.
Diffusion tensor imaging (b¼ 0 and 1000 s/mm2) was
scanned with the following: single shot echo-planar
imaging (EPI); TR¼ 5800ms; TE¼ 92ms; flip angle
(FA)¼ 90; slice thickness¼ 3mm; slice gap¼ 3mm;
field of view (FOV)¼ 230 230mm; matrix¼ 256
256; bandwidth¼ 1565Hz/pixel; no averages. Diffusion
gradients (40 mT/m) in 12 directions; 37 transverse
slices; acquisition time¼ 2.2 min. ADC maps were cal-
culated on the scanner. Finally, DSC perfusion: 70
transversal time series (EPI, epfid2d1); temporal reso-
lution¼ 1.0 s; gadoterate meglumine (Gd-DOTA,
Dotarem, Guerbet, 0.1mmol/kg): TR¼ 1000ms;
TE¼ 40ms; FA¼ 60; slice thickness¼ 6mm; slice
gap¼ 7.8mm; FOV¼ 230 230mm; matrix¼ 256
256; and bandwidth¼ 1500 Hz/pixel.
Defining the lesions
All patients’ images were clinically interpreted by neu-
roradiologists with >10 years of experience. Three
independent observers then analyzed the lesions: an
expert neuro-radiologist with >10 years of experience
(Observer 1); a radiology resident (Observer 2), and a
medical physicist without any experience in brain imag-
ing (Observer 3). All lesions were analyzed off-line
(Matlab 2014a, The Mathworks, Natick, MA, USA).
Three different methods were used to define the ROI.
In method 1, a circle was drawn independently and
with varying diameters to include the lowest pixel
values on the ADC map and highest pixel values on
the DSC time series at the time-point with the highest
contrast enhancement (Fig. 1). These small ROIs had
an average diameter of 9.1mm (range¼ 3.7–17.8mm).
The lowest or highest region in the tumor was located
in the tumor by visual evaluation and quantitative
measurements of the pixel values. The diameter of the
circle was adjusted according to the estimation of the
observer. Additionally, freeform ROIs were drawn to
encompass the whole tumor at the largest MRI cross-
section only (method 2: 2D; Fig. 2; area¼ 184–
5140mm2) or summed MRI cross-sections (method 3:
3D; Fig. 3; area¼ 577–46,121mm2).
DSC-MRI quantification
Voxelwise analysis of the DSC curve was performed to
obtain the following parameters: maximum contrast
enhancement (MCE); time-to-peak (TTP); wash-in
rate (Win); wash-out rate (Wout); and the relative cere-
bral blood volume (rCBV).
Three time-points were defined: tonset¼ 10 s after
start of the sequence; tmax¼ time at the peak of the
signal; and tend¼ last time point of DSC curve. Win
was calculated by the slope of a linear fit of the signal
between tonset and tmax. Wout was calculated by the
slope of a linear fit of the signal between tmax and
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tend. MCE was defined as (Smax–Sonset)/Sonset, where
Smax is the signal intensity at maximum contrast
enhancement and Sonset is the signal without contrast
enhancement at tonset. TTP is the time between tonset
and tmax. The rCBV was calculated by numerical inte-
gration of DR2*¼ -ln(S/Sonset)/TE (15), where S is the
signal intensity. DR2* was not divided by the result for
contralateral or centrum ROIs in order to obtain ICC
values not complicated by additional ROI settings.
Comparisons and statistics
Statistical analyses were performed using SPSS (SPSS
23, Chicago, IL, USA). All data were tested for
normality using Shapiro–Wilk tests. The ICCs between
observers was calculated for all three methods using a
two-way mixed model, single measures after applying a
log transformation to normalize the PWI data. Low-
and high-grade lesions were compared using indepen-
dent t-tests for ADC data and Mann–Whitney tests
for PWI data. The mean of all voxels in the circular
ROI was taken to define the ADC, rCBV, MCE, TTP,
Win, and Wout for each lesion for all methods. For the
freehand 2D and 3D methods, next to the mean, four
additional statistics were calculated by histogram anal-
ysis for ADC, rCBV,MCE, TTP,Win, andWout: the 5%
and 10% lowest values in the lesion (min5% and
min10%) and the 5% and 10% highest values in the
Fig. 2. Method 2, 2D freeform ROI method. A 54-year-old man with a glioblastoma (high-grade). A freeform ROI encompassing the
whole tumor was drawn at the largest tumor cross-section, independently on the ADC map (left) and on the PWI map (right).
ROI: region of interest; ADC: apparent diffusion coefficient; PWI: perfusion-weighted imaging.
Fig. 1. Method 1, conventional small circle ROI. A 54-year-old man with a glioblastoma (high-grade). Circles of free diameter were
drawn independently to include the lowest pixel values on the ADC map (left) and the highest pixel value on the PWI map (right).
ROI: region of interest; ADC: apparent diffusion coefficient; PWI: perfusion-weighted imaging.
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lesion (max5% and max10%) for each parameter. For
both freehandmethods, the best statistic was determined
based on the highest ICC and best differentiation (high-
est significance) between low- and high-grade lesions.
For the conventional small circle ROI, only the mean
of the circle was used. A Ptwo-sided< 0.05 was considered
a statistically significant difference for all tests.
Results
Histopathology of 30 lesions resulted in 13 low-grade
and 17 high-grade gliomas: 12 astrocytoma (Grade II);
one oligoastrocytoma (Grade II); 13 glioblastoma
(Grade IV); three anaplastic astrocytoma (Grade III);
and one anaplastic oligodendroglioma (Grade III).
Inter-observer reproducibility
The Shapiro–Wilk tests showed that within the chosen
ROIs the pixel value distributions for ADC and five
PWI parameters (rCBV, MCE, TTP, Win, Wout) were
generally normal after the log transformation, so ICC
were assessed for the mean values (Table 1).
Low-grade gliomas presented with sufficient signal
change on both ADC and PWI maps to accurately
draw the contours, as demonstrated in the example in
Fig. 3. Method 3, 3D volume ROI method. A 54-year-old man with a glioblastoma (high-grade). ROIs were drawn independently on
the ADC map (A) and on the PWI map (B); the tumor was visible on all slices, yielding summed voxels approximating the whole 3D
volume of the lesion.
ROI: region of interest; ADC: apparent diffusion coefficient; PWI: perfusion-weighted imaging.
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Fig. 4. For all six parameters, inter-observer agreement
of the mean values was better for 2D and 3D freeform
ROIs (ICC¼ 0.836–0.986) than for circular ROIs
(ICC¼ 0.141–0.641).
Differentiation of low- and high-grade gliomas
For PWI, both freeform 2D and 3D methods yielded
significant differences between low- and high-grade gli-
omas when comparing the mean, max5%, or max10%
Fig. 3. Continued
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of either TTP (P 0.015) or rCBV (P 0.001), as
documented in Table 2. For Win (P 0.004) or Wout
(P 0.007) the min5% and min10% resulted in signif-
icant differences for both methods. MCE as assessed by
any ROI method yielded no significant differences
between low and high grade (P 0.127).
For DWI, the ADC differentiated significantly
(P 0.048) between low- and high-grade gliomas
when choosing the minimum 5% or 10% of pixel
values of the 2D and 3D freeform ROIs; however,
reproducibility was low (ICC¼ 0.532–0.622). In
addition, for the circular ROI method, the ADC
was the only parameter yielding significant
differences with reasonable inter-observer agreement
(P< 0.001, ICC¼ 0.641).
Overall, the best ICC with significant grade differ-
entiation could be obtained for the TTP parameter
measured on a freeform 3D (ICC¼ 0.986, P¼ 0.015)
and using the mean as measurement statistic
(Table 3), closely followed by the result from a free-
form 2D ROI (ICC¼ 0.974, P¼ 0.004).
Discussion
This study showed that inter-observer agreement
increased when gliomas were encompassed with a 2D
Table 1. Inter-observer reproducibility.
Method Statistic ADC MCE TTP Win Wout rCBV
Circle Mean 0.641 0.204 0.314 0.325 0.141 0.405
2D Mean 0.854 0.890 0.974 0.876 0.892 0.923
Min5% 0.532 0.839 0.923 0.552 0.620 0.861
Min10% 0.554 0.844 0.926 0.677 0.860 0.705
Max5% 0.639 0.905 0.860 0.888 0.922 0.814
Max10% 0.749 0.903 0.874 0.890 0.926 0.842
3D Mean 0.836 0.897 0.986 0.911 0.935 0.961
Min5% 0.622 0.904 0.878 0.743 0.745 0.708
Min10% 0.588 0.905 0.873 0.826 0.769 0.507
Max5% 0.755 0.912 0.927 0.923 0.973 0.908
Max10% 0.821 0.907 0.935 0.929 0.966 0.923
Three different methods were used to define the ROI (circle, 2D, and 3D). For each method, the six MRI parameters were calculated by using the mean
or 5% or 10% lowest or respectively highest values in the ROI. The intraclass correlation coefficient (ICC) was determined for all combinations.
ROI: region of interest; ADC: apparent diffusion coefficient; MCE: maximum contrast enhancement; TTP: time-to-peak; Win: wash-in rate; Wout: wash-
out rate; rCBV: relative cerebral blood volume.
Fig. 4. Example of low-grade tumor assessed using the 2D freeform ROI method. A 37-year-old woman with an astrocytoma.
A freeform ROI encompassing the whole tumor was drawn at the largest tumor cross-section, independently on the ADC map (left)
and on the PWI map (right).
ROI: region of interest; ADC: apparent diffusion coefficient; PWI: perfusion-weighted imaging.
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freeform ROI compared to the conventional small
circle ROI, while 3D freeform ROIs yielded no addi-
tional benefits.
Our finding of best reproducibility of whole tumor
freeform ROI for the five DSC parameters, as well as
ADC, compared with small circles of variable size
positioned at highest PWI map and lowest ADC, is
hard to compare with previous studies. Some only
used small circular or elliptical ROIs of 20–40mm2
(9–11,16) compared to others that only used freeform
ROIs to delineate tumors (7,8,12–14), sometimes sup-
plemented with “minimum ADC” (8) or lower and
pixel value means for ADC (12). In just one study,
both small presumably circular “hot spot” ROIs of
25–30mm2 were set for each DSC parameter and
compared with freeform ROI (7). Their conclusion
that “hot spot ROI” analysis in DSC showed the
best correlation with grading of gliomas appears to
be at odds with our result. No assessment of repro-
ducibility by ICC comparison was provided in that
comparatively small study of nine low-grade gliomas
and 17 high-grade ones (7).
In our case, reproducibility and differentiation was
best for rCBV and TTP which apparently reflected the
comparatively high ICC values obtained for these two
DSC parameters in 2D and 3D freeform ROI. That the
freehand mean and max5–10% offered the best differ-
entiation for these parameters leads to the interpreta-
tion that the highest blood volume and enhancement
delay encountered in glioma are most characteristic for
tumor grade. In contrast, the rates of Win and Wout
offered best differentiation at freeform ROI
min5–10%. This fits with the knowledge that increased
transfer rates are typical for malignancy (7–10,12).
Table 3. Comparison of optimal ROI settings and statistic.
Conventional circle 2D freeform 3D freeform
Statistic ICC
Low-/high-
grade P Statistic ICC
Low-/high-
grade P Statistic ICC
Low-/high-
grade P
ADC (mm2/s) Mean 0.641* <0.001* Min10% 0.554* 0.048* Min5% 0.622* 0.005*
MCE Mean 0.204* 0.968 Min5% 0.839* 0.127 Min5% 0.904* 0.246
TTP (s) Mean 0.314* 0.159 Mean 0.974* 0.004* Mean 0.986* 0.015*
Win (s
–1) Mean 0.325* 0.151 Min10% 0.677* <0.001* Min10% 0.826* 0.004*
Wout (s
–1) Mean 0.141 0.027* Min10% 0.860* <0.001* Min10% 0.769* 0.007*
rCBV Mean 0.405* 0.002* Mean 0.923* <0.001* Mean 0.961* <0.001*
For the 2D and 3D freeform method the best statistic is indicated based on the highest ICC and best differentiation between low- and high-grade
lesions. For the conventional circle ROI only the mean of the circle was used.
*P< 0.05.
ROI: region of interest; ADC: apparent diffusion coefficient; MCE: maximum contrast enhancement; PWI: perfusion-weighted imaging; ROI: region of
interest; TTP: time-to-peak; Win: wash-in rate; Wout: wash-out rate; rCBV: relative cerebral blood volume.
Table 2. Differentiation between low- and high-grade gliomas.
Method Statistic ADC MCE TTP Win Wout rCBV
Circle Mean <0.001* 0.968 0.159 0.151 0.027* 0.002*
2D Mean 0.189 0.987 0.004* 0.481 0.379 <0.001*
Min5% 0.045* 0.127 0.022* <0.001* <0.001* 0.416
Min10% 0.048* 0.169 0.156 <0.001* <0.001* 0.772
Max5% 0.595 0.842 <0.001* 0.715 0.927 <0.001*
Max10% 0.726 0.855 <0.001* 0.753 0.927 <0.001*
3D Mean 0.131 0.693 0.015* 0.497 0.085 <0.001*
Min5% 0.005* 0.246 0.062 0.004* 0.005* 0.432
Min10% 0.009* 0.381 0.364 0.004* 0.007* 0.599
Max5% 0.265 0.723 <0.001* 0.855 0.413 <0.001*
Max10% 0.238 0.766 <0.001* 0.874 0.373 <0.001*
Three different methods were used to define the ROI (circle, 2D and 3D). For each method the six MRI parameters were calculated by using the mean
or 5% or 10% lowest or respectively highest values in the ROI. The significance of the differences between low- and high-grade was determined for all
combinations.
*P< 0.05.
ROI: region of interest; ADC: apparent diffusion coefficient; MCE: maximum contrast enhancement; TTP: time-to-peak; Win: wash-in rate; Wout: wash-
out rate; rCBV: relative cerebral blood volume.
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Note that the most basic PWI parameter, MCE,
though highly reproducible at especially 3D-freeform
ROI max5% and max10% (ICC¼ 0.907–0.912), did
not differentiate between low- and high-grade gliomas
(P> 0.7). This is in line with a previous study showing
that rCBV is a stronger predictor of glial tumor grade
than the degree of enhancement (5).
The DWI parameter ADC was the only one provid-
ing significant grade differentiation along with reason-
able reproducibility (ICC> 0.641) for the circular ROI,
despite its lower ICC values compared with freeform
2D and 3D ROI. The worse result in terms of grade
differentiation when just taking the mean of a freeform
2D or 3D ROI indicates that low ADC values are prob-
ably clustered in a limited part of the tumor and thus
averaged out when taking the mean of the entire ROI.
This is confirmed by the finding by Perez et al., that the
ADC was worse in differentiating between glioma
grades than a couple of DSC parameters when just
taking the mean of the ROI (8). However, when
taking the minimal ADC value of the ROI, they
observed significant differentiation between glioma
grades by the ADC, which is in accordance with our
results. In addition, other compounds, such as fatty
acids and calcifications, potentially present in oligoden-
droglioma, can affect the minimal ADC of a tumor
which can be avoided by a manually selected area of
low diffusion with a circle ROI (17,18).
Results obtained from multiple summed tumor slices
(3D freeform ROI) were similar to those obtained with
2D freeform ROI, both in terms of reproducibility and
in terms of tumor grade differentiation. It was expected
that the circular ROIs would result in a lower repro-
ducibility than the freeform methods because the circu-
lar diameters and locations were set differently by
different observers. Another fair assumption is that
the freeform 3D method, including the whole tumor,
would result in better reproducibility than the freeform
2D method. Due to the heterogeneity of the tumor,
especially for the high-grade glioma, one slice analysis,
as applied in the freeform 2D method, might not reflect
the features of the whole tumor. Our results of 3D
analysis were, however, similar to the 2D analysis.
The statistics such as min5% and max5% are already
sensitive for the small number of pixels deviating from
the mean in the 2D freeform slice. For tumor charac-
terization, the 3D analysis therefore had no incremen-
tal value beyond the 2D freeform region. This might
indicate that in the analysis of glioma, evaluation of a
single 2D freeform region of the largest cross-section of
the tumor might be sufficient, especially considering the
time needed to draw the regions.
A limitation in our study was that only 30 patients
were included. However, the results of this study docu-
mented that this was sufficient, considering that the
reported observations generally meet high levels of sig-
nificance (P< 0.001). Another issue was that ROIs
were set independently for the DWI analysis and for
the DSC analyses. This had the limitation that it made
no sense to associate the ADC parameter values to
those derived from DSC. Apart from that, it might
even be best to set “hot spot” ROIs independently for
each DSC parameter to account for tumor heterogene-
ity (7,9,10). Another limitation was that our analyses
were performed off-line by Matlab. More consistent
results could be obtained by more or less automated
software packages such as Olea or NordicIce, although
inter-software reproducibility has been found to be
poor (16). The three observers in our study were of
mixed levels of experience with neuroradiology, which
turned out to be no real limitation as evidenced by the
tabulated ICC values of up to 0.99. It has been shown
that combining perfusion and DWI parameters can
improve glioma grading accuracy (7,9,13,14), but
exploration of that was beyond the scope of the present
study aiming at the effects of ROI definition on the
robustness of separate DSC parameters and ADC in
relation to their potential to differentiate between low-
and high-grade gliomas. Another topic, not explored in
this study, with standard clinical DWI acquisitions of
just 2 b values, is that with biexponential intravoxel
incoherent motion (IVIM) analysis of DWI data differ-
entiation between low- and high-grade glioma and
other brain tissue types may improve (19).
In conclusion, DSC perfusion parameters rCBV and
TTP yielded high inter-observer reproducibility and
significant glioma grade differentiation for the means
of 2D and 3D freeform ROIs. However, the more time-
consuming alternative of 3D freeform ROI did not pro-
vide addition benefit. The small circular ROI yielded
only significant differences with reasonable reproduc-
ibility for the DWI parameter ADC.
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